MoneyWorks4Me

Brooks Laboratorie informs about updates

22 Aug 2022 Evaluate
Brooks Laboratorie has informed that it enclosed update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per via land 1 gram per vial (the product) from the United States Food & Drug Administration (USFDA).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..